![]() |
Health care providers play a critical role in sharing information with their patients about COVID-19 and immunization. Additional information on vaccine development, authorized vaccines and vaccine is available through the federal government’s COVID-19 Vaccination Tool Kit for Health Care Providers.
Manitoba COVID-19 Vaccine: Clinical Practice Guidelines for Immunizers and Health Care Providers (pdf, May 3, 2022)
April 2022
Manitoba COVID-19 Vaccine: Novavax, 12-17 year old and 18+ First Boosters (pdf, April 13, 2022)
Manitoba COVID-19 Vaccine: Second Booster Recommendations and Moderna for 6-11 years of age (pdf, April 6, 2022)
COVID-19 Vaccine: Booster Dose Guidance for Adolescents (pdf, February 4, 2022)
COVID-19 Vaccine: Clarifying Recommended and Minimum Intervals (pdf, January 12, 2022)
COVID-19 Vaccine: Moderna for individuals aged ≥ 30 years (pdf, December 31, 2021)
COVID-19 Vaccine: updated third/booster dose interval for individuals aged ≥ 50 years and updated vaccine product for individuals aged ≥ 30 years (pdf, December 24, 2021)
COVID-19 Vaccine: updated third/booster dose guidance and preferential use of Pfizer/ComirnatyTM for 12 to 29 year olds (pdf, December 10, 2021)
COVID-19 Vaccine: Approval/Guidance for Children aged five to ≤ 11 years (pdf, November 23, 2021)
COVID-19 Vaccine Update: Pharmacists to Start Administering COVID-19 and Influenza Vaccines to Those Five Years of Age and Older (pdf, November 16, 2021)
COVID-19 Vaccine Update: Expanded Third/ Booster Dose 6 Months After Dose 2 Guidance (pdf, November 10, 2021)
COVID-19 Vaccine: Third/Booster Dose Update (pdf, November 5, 2021)
COVID-19 Vaccine RE: Important Program Updates (pdf, November 3, 2021)
Moderna/Spikevax - Shelf life extension for US Labeled 14 dose vials (pdf, October 29, 2021)
COVID-19 Vaccine: Booster/Third Dose Guidance and Expansion to Include Residents of Congregate Elderly Person Housing Sites (pdf, October 27, 2021)
COVID-19 Vaccine Medical Exemption Program (pdf, October 6, 2021)
COVID-19 Vaccine: Expansion of Third Doses to Health Care Personnel and to People who received a Viral Vector Vaccine Series (pdf, October 5, 2021)
Manitoba Adopting National Advisory Committee on Immunization (NACI) Guidance (pdf, October 1, 2021)
COVID-19 Vaccine Guidance for Personal Care Homes: Recommended Interval between Second and Third Doses of COVID-19 Vaccine & Update on COVID-19/Flu Vaccine Sequence of Administration (pdf, September 23, 2021)
COVID-19 Vaccine: Expansion of Third Doses to Personal Care Homes (pdf, September 20, 2021)
COVID-19 Vaccine: Additional Information on Third Doses (pdf, September 17, 2021)
COVID-19 Vaccine: Additional mRNA Vaccine Dose for Certain Populations and Medical Exemption Program (pdf, September 15, 2021)
Reporting COVID-19 and School Vaccine Doses Administered to Clients without a PHIN (pdf, September 2021)
Pfizer - Shelf life extension for identified lots in Ultra Low Temperature Storage (pdf, August 30, 2021)
COVID-19 Vaccine: Recommendations for Immunizing Adolescents (pdf, August 2021)
COVID-19 Vaccine: Updated Age Eligibility Criteria for Children (pdf, August 2021)
COVID-19 Vaccine: Allergy Assessment and Referral (pdf, June 2021)
IMPORTANT NOTICE: Effective immediately, pause use of AstraZeneca / COVISHIELD in People aged < 55 years (pdf, March 29, 2021)
First Nations Identification for the Purpose of Booking AstraZeneca/ Covishield Vaccination (pdf, March 29, 2021)
Manitoba COVID-19 Vaccine: Updated AstraZeneca and COVISHIELD Product Monographs and Health Product Risk Communication (pdf, March 25, 2021)
Health Product Risk Communication: Important Safety Information on AstraZeneca and COVISHIELD Vaccines (pdf, March 24, 2021)
COVID-19 Vaccine: New/Updated Communications Products including Clinical Practice Guidelines and Consent Form (pdf, March 15, 2021)
COVID-19 Vaccine: Guidance for Immunizers to Select the Reason for Immunization (pdf, March 2, 2021)
Memo to Health Care Providers on Enhanced Consent (pdf, January 25, 2021)
Pfizer BioNTech - Information for health care providers (manufacturer site)
CanVax: COVID-19 Vaccine Questions and Answers for Healthcare Providers
Memo to Health Care Providers (pdf, December 15, 2020)